[1]孟祥慧,徐书杭,蔡可英,等.肥胖与甲状腺癌:临床新启示[J].国际内分泌代谢杂志,2014,(02):87-89.[doi:10.3760/cma.j.issn.1673-4157.2014.02.005]
 Meng Xianghui*,Xu Shuhang,Cai Keying,et al.Obesity and thyroid cancer: a new clinical implication[J].International Journal of Endocrinology and Metabolism,2014,(02):87-89.[doi:10.3760/cma.j.issn.1673-4157.2014.02.005]
点击复制

肥胖与甲状腺癌:临床新启示()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
期数:
2014年02期
页码:
87-89
栏目:
甲状腺疾病专栏
出版日期:
2014-04-30

文章信息/Info

Title:
Obesity and thyroid cancer: a new clinical implication
作者:
孟祥慧徐书杭蔡可英刘超
210028 南京,中国中医科学院江苏分院,南京中医药大学附属中西医结合医院内分泌代谢病院区(孟祥慧,徐书杭,刘超);221006  徐州医学院第二附属医院内分泌科(蔡可英)   
Author(s):
Meng Xianghui*Xu ShuhangCai KeyingLiu Chao.
*Endocrine and Diabetes Center,Jiangsu Province Hospital on Integration of Chinese and Western Medicine,Nanjing University of Traditional Chinese Medicine,Jiangsu Branch of China Academy of Chinese Medical Science,Nanjing 210028,China Corresponding author
关键词:
肥胖甲状腺癌
Keywords:
ObesityThyroid cancer
DOI:
10.3760/cma.j.issn.1673-4157.2014.02.005
摘要:
甲状腺癌的患病率逐年增加,越来越多的研究表明肥胖可能增加其患病风险,且女性肥胖人群的甲状腺癌患病率显著增加。目前认为,胰岛素抵抗、高胰岛素血症、脂肪因子、促甲状腺激素和雌激素是较有可能参与肥胖致甲状腺癌过程的重要因素。但仍需要更多研究明确肥胖对甲状腺癌的影响及其机制,这将有助于肥胖和甲状腺癌的防治。
Abstract:
Along with the rising prevalence of thyroid cancer,more and more evidence showed that obesity might play an important role in thyroid tumorigenesis. This association is stronger in female. Insulin resistance,hyperinsulinemia,adipokines,thyrotropin and estrogen may participate in the development of obesity-related thyroid cancer. However,further research is required to clarify the effects of obestity on thyroid tumour and the underlying mechanism,which is essential to the treatment and prevention of both diseases.

参考文献/References:

 [1] Renehan AG,Tyson M,Egger M,et al. Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies[J]. Lancet,2008,371(9612):569-578.  
[2] Dal Maso L,La Vecchia C,Franceschi S,et al. A pooled analysis of thyroid cancer studies. V. Anthropometric factors[J]. Cancer Causes Control,2000,11(2):137-144.  
[3] Kitahara CM,Platz EA,Freeman LE,et al. Obesity and thyroid cancer risk among U.S. men and women:a pooled analysis of five prospective studies[J]. Cancer Epidemiol Biomarkers Prev,2011,20(3): 464-472.  
[4] Rapp K,Schroeder J,Klenk J,et al. Obesity and incidence of cancer: a large cohort study of over 145,000 adults in Austria[J]. Br J Cancer,2005,93(9):1062-1067.  
[5] Iribarren C,Haselkorn T,Tekawa IS,et al. Cohort study of thyroid cancer in a San Francisco Bay area population[J]. Int J Cancer, 2001,93(5):745-750.  
[6] Guignard R,Truong T,Rougier Y,et al. Alcohol drinking,tobacco smoking,and anthropometric characteristics as risk factors for thyroid cancer:a countrywide case-control study in New Caledonia[J]. Am J Epidemiol,2007,166(10):1140-1149.  
[7] Han JM,Kim TY,Jeon MJ,et al. Obesity is a risk factor for thyroid cancer in a large,ultrasonographically screened popula-tion[J]. Eur J Endocrinol,2013,168(6):879-886.  
[8] Meinhold CL,Ron E,Schonfeld SJ,et al. Nonradiation risk factors for thyroid cancer in the US Radiologic Technologists Study[J]. Am J Epidemiol,2010,171(2):242-252.  
[9] Clavel-Chapelon F,Guillas G,Tondeur L,et al. Risk of differentiated thyroid cancer in relation to adult weight,height and body shape over life:the French E3N cohort[J]. Int J Cancer,2010,126(12):2984-2990.
[10] Leitzmann MF,Brenner A,Moore SC,et al. Prospective study of body mass index,physical activity and thyroid cancer[J]. Int J Cancer, 2010,126(12):2947-2956.
[11] Engeland A,Tretli S,Akslen LA,et al. Body size and thyroid cancer in two million Norwegian men and women[J]. Br J Cancer,2006, 95(3):366-370.
[12] Harari A,Endo B,Nishimoto S,et al. Risk of advanced papillary thyroid cancer in obese patients[J]. Arch Surg,2012,147(9):805-811.
[13] Kim HJ,Kim NK,Choi JH,et al. Associations between body mass index and clinico-pathological characteristics of papillary thyroid cancer[J]. Clin Endocrinol(Oxf),2013,78(1):134-140.
[14] Paes JE,Hua K,Nagy R,et al. The relationship between body mass index and thyroid cancer pathology features and out-comes:a clinicopathological cohort study[J]. J Clin Endocrinol Metab,2010,95(9): 4244-4250.
[15] Rezzónico JN,Rezzónico M,Pusiol E,et al. Increased preva-lence of insulin resistance in patients with differentiated thyroid carcinoma[J]. Metab Syndr Relat Disord,2009,7(4):375-380.
[16] Chen G,Xu S,Renko K,et al. Metformin inhibits growth of thyroid carcinoma cells,suppresses self-renewal of derived cancer stem cells,and potentiates the effect of chemotherapeutic agents[J]. J Clin Endocrinol Metab,2012,97(4):E510-E520.
[17] Fiore E,Vitti P. Serum TSH and risk of papillary thyroid cancer in nodular thyroid disease[J]. J Clin Endocrinol Metab,2012,97(4): 1134-1145.
[18] Hedayati M,Yaghmaei P,Pooyamanesh Z,et al. Leptin:a correlated Peptide to papillary thyroid carcinoma?[J]. J Thyroid Res,2011, 2011:832163.
[19] Uddin S,Bavi P,Siraj AK,et al. Leptin-R and its association with PI3K/AKT signaling pathway in papillary thyroid carci-noma[J]. Endocr Relat Cancer,2010,17(1):191-202.
[20] Cheng SP,Yin PH,Hsu YC,et al. Leptin enhances migration of human papillary thyroid cancer cells through the PI3K/AKT and MEK/ERK signaling pathways[J]. Oncol Rep,2011,26(5):1265-1271.
[21] Mitsiades N,Pazaitou-Panayiotou K,Aronis KN,et al. Circulating adiponectin is inversely associated with risk of thyroid cancer:in vivo and in vitro studies[J]. J Clin Endocrinol Metab,2011,96(12): E2023-E2028.
[22] Cheng SP,Liu CL,Hsu YC,et al. Expression and biologic significance of adiponectin receptors in papillary thyroid carcinoma[J]. Cell Biochem Biophys,2013,65(2):203-210.
[23] Brindel P,Doyon F,Rachédi F,et al. Anthropometric factors in differentiated thyroid cancer in French Polynesia:a case-control study[J]. Cancer Causes Control,2009,20(5):581-590.
[24] Pappa T,Alevizaki M. Obesity and Thyroid Cancer:A Clinical Update[J]. Thyroid.2013 Sep 25. [Epub ahead of print]
[25] Xu S,Chen G,Peng W,et al. Oestrogen action on thyroid progenitor cells:relevant for the pathogenesis of thyroid nodules?[J]. J Endocrinol,2013,218(1):125-133.
[26] Kitahara CM,Platz EA,Beane Freeman LE,et al. Physical activity,diabetes,and thyroid cancer risk:a pooled analysis of five prospective studies[J]. Cancer Causes Control,2012,[Epub ahead of print]
[27] Cash SW,Ma H,Horn-Ross PL,et al. Recreational physical activity and risk of papillary thyroid cancer among women in the California Teachers Study[J]. Cancer Epidemiol,2013,37(1):46-53.
[28] Kelly DP. Medicine. Irisin,light my fire[J]. Science,2012,336(6077):42-43.

相似文献/References:

[1]于亚静 杨彩哲 关小宏 王良宸 吴石白 刘明 肖黎 张妲 刘朝阳.甲状腺癌与桥本甲状腺炎及其他相关危险因素的研究[J].国际内分泌代谢杂志,2015,(01):27.[doi:10.3760/cma.j.issn.1673-4157.2015.01.006]
 Yu Yajing*,Yang Caizhe,Guan Xiaohong,et al.Relationship between thyroid carcinoma, Hashimoto′s thyroiditis and other related risk factors[J].International Journal of Endocrinology and Metabolism,2015,(02):27.[doi:10.3760/cma.j.issn.1673-4157.2015.01.006]
[2]刘艳清 易秋艳 邵加庆.肠道菌群与肥胖和糖尿病的关系[J].国际内分泌代谢杂志,2015,(01):31.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.007]
 Liu Yanqing,Yi Qiuyan,Shao Jiaqing..Relationship between gut microbiota, obesity and diabetes[J].International Journal of Endocrinology and Metabolism,2015,(02):31.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.007]
[3]姚旻 赵爱源 张宏.肠道菌群与2型糖尿病[J].国际内分泌代谢杂志,2015,(01):35.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.008]
 Yao Min*,Zhao Aiyuan,Zhang Hong..Relationship between gut microbiota and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2015,(02):35.[doi:DOI:10.3760/cma.j.issn.1673-4157.2015.01.008]
[4]胡明玥 沈山梅.棕色脂肪检测技术的研究进展[J].国际内分泌代谢杂志,2015,(01):41.[doi:10.3760/cma.j.issn.1673-4157.2015.01.010]
 Hu Mingyue*,Shen Shanmei..Assessments of brown adipose tissue Hu Mingyue*,Shen Shanmei.*Medical College of Southeast University,Nanjing 210009,China[J].International Journal of Endocrinology and Metabolism,2015,(02):41.[doi:10.3760/cma.j.issn.1673-4157.2015.01.010]
[5]李兴佳 曹萌 刘超.自噬与甲状腺癌的关系[J].国际内分泌代谢杂志,2015,(01):56.[doi:10.3760/cma.j.issn.1673-4157.2015.01.014]
 Li Xingjia,Cao Meng,Liu Chao..Relationship between autophagy and thyroid cancer[J].International Journal of Endocrinology and Metabolism,2015,(02):56.[doi:10.3760/cma.j.issn.1673-4157.2015.01.014]
[6]郑仁东,曹琳,刘克冕,等.超重或肥胖的男性2型糖尿病患者 性激素水平的研究[J].国际内分泌代谢杂志,2015,(02):84.[doi:10.3760/cma.j.issn.1673-4157.2015.02.004]
 Zheng Rendong,Cao Lin,Liu Kemian,et al.Study on sex hormone levels in overweight or obese type 2 diabetic male patients[J].International Journal of Endocrinology and Metabolism,2015,(02):84.[doi:10.3760/cma.j.issn.1673-4157.2015.02.004]
[7]王滢,李倩.脑利钠肽与糖脂代谢的关系[J].国际内分泌代谢杂志,2015,(02):103.[doi:10.3760/cma.j.issn.1673-4157.2015.02.008]
 Wang Ying,Li Qian..Association between brain natriuretic peptide and glycolipid metabolism[J].International Journal of Endocrinology and Metabolism,2015,(02):103.[doi:10.3760/cma.j.issn.1673-4157.2015.02.008]
[8]王兴纯,程晓芸,曲伸.代餐饮食对代谢紊乱改善的作用及其机制[J].国际内分泌代谢杂志,2015,(02):106.[doi:10.3760/cma.j.issn.1673-4157.2015.02.009]
 Wang Xingchun,Cheng Xiaoyun,Qu Shen..Roles of meal replacement in the improvement of metabolic disorders and related mechanism[J].International Journal of Endocrinology and Metabolism,2015,(02):106.[doi:10.3760/cma.j.issn.1673-4157.2015.02.009]
[9]贺肴,张弛,刘瑛,等.代谢正常肥胖合并非酒精性脂肪性肝病的临床特征及内皮功能研究[J].国际内分泌代谢杂志,2015,(03):163.[doi:10.3760/cma.j.issn.1673-4157.2015.03.005]
 He Yao,Zhang Chi,Liu Ying,et al.Clinical features and endothelial function in metabolically healthy obese patients with nonalcoholic fatty liver disease[J].International Journal of Endocrinology and Metabolism,2015,(02):163.[doi:10.3760/cma.j.issn.1673-4157.2015.03.005]
[10]黄莉吉,谢绍锋,刘超.肥胖相关性肾病的研究进展[J].国际内分泌代谢杂志,2015,(03):180.[doi:10.3760/cma.j.issn.1673-4157.2015.03.010]
 Huang Liji*,Xie Shaofeng,Liu Chao..Obesity-related glomerulopathy[J].International Journal of Endocrinology and Metabolism,2015,(02):180.[doi:10.3760/cma.j.issn.1673-4157.2015.03.010]

备注/Memo

备注/Memo:
通信作者:刘超,Email: liuchao@nfmcn.com
更新日期/Last Update: 2014-03-20